Table 1 Screening characteristics
DM only | CVD only | CVD+DM | |
|---|---|---|---|
n = 2584 | n = 1748 | n = 6397 | |
Age (years) | 62 (± 6) | 64 (± 6) | 64 (± 6) |
Male gender (%) | 38% | 66% | 64% |
BMI (kg/m 2 ) | 35.9 (± 4.8) | 33.4 (± 4.1) | 34.0 (± 4.4) |
Weight (kg) | 97.4 (± 16.1) | 95.0 (± 14.8) | 95.8 (± 15.4) |
Waist circumference, men (cm) | 117 (± 12) | 112 (± 10) | 114 (± 10) |
Waist circumference, women (cm) | 111 (± 12) | 104 (± 11) | 109 (± 11) |
Systolic blood pressure (mmHg) | 141 (± 12) | 136 (± 13) | 138 (± 13) |
Diastolic blood pressure (mmHg) | 78 (± 8) | 78 (± 8) | 77 (± 9) |
Pulse (bpm) | 75 (± 10) | 68 (± 10) | 71 (± 10) |
Creatinine clearance (mL/min/1.73 m 2 ) | 76 [48;105] | 72 [47;99] | 71 [41;103] |
Uric acid concentration (μmol/L) | 342 (± 87) | 369 (± 86) | 374 (± 98) |
Glucose concentration (mmol/L) | 9.0 (± 3.1) | 6.0 (± 1.0) | 8.9 (± 3.2) |
HDL cholesterol (mmol/L) | 1.3 (± 0.3) | 1.2 (± 0.3) | 1.2 (± 0.3) |
LDL cholesterol (mmol/L) | 3.1 (± 0.9) | 3.0 (± 0.9) | 3.0 (± 1.0) |
Triglycerides (mmol/L) | 2.2 (± 1.5) | 2.0 (± 1.1) | 2.4 (± 1.4) |
History of dyslipidaemia (%) | 71% | 76% | 86% |
History of stroke (%) | 0% | 9% | 12% |
Peripherial artery disease (%) | 0% | 8% | 16% |
Use of alcohol (%) | 51% | 63% | 54% |
Current smokers (%) | 11% | 10% | 9% |
Coronary artery disease (%) | 4% | 87% | 83% |
CHF (%) | 2% | 9% | 11% |
Use of diuretics (%) | 45% | 37% | 51% |
Use of Insulin (%) | 26% | 0.5% | 32% |
Use of statins (%) | 42% | 73% | 73% |
Use of ACE-inhibitors (%) | 73% | 64% | 82% |
Use of Ca 2+ -blockers (%) | 32% | 33% | 40% |
Use of fibrates (%) | 10% | 6% | 10% |
Urinary dip stick for glucose: | |||
Negative (%) | 81% | 99% | 79% |
Trace (%) | 6% | 0.4% | 6% |
1+ (%) | 4% | 0.2% | 5% |
2+ (%) | 3% | 0.1% | 3% |
3+ (%) | 6% | 0.4% | 6% |